We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $418.00. The company’s shares closed ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled ...

VERTEX traders use a wide range of trading signals and technical indicators to predict a price's trajectory. While not all methods are necessary to accurately forecast the direction of the market, ...

AI VERTEX by Virtuals (VERTEX) is a digital asset with a market capitalization of $0.00. AI VERTEX by Virtuals is ranked as number in the global cryptocurrency rating with a 24-hour trading volume of ...

In the latest market close, Vertex Pharmaceuticals (VRTX) reached $409.56, with a -0.62% movement compared to the previous day. This change was narrower than the S&P 500's 1.54% loss on the day.

Ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) were provided by 23 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise ...

Most everyone has used Zoom since the pandemic, but have you mastered virtual backgrounds and filters? I interviewed Zoom expert Christopher G. Johnson for advice. Who is Christopher G. Johnson? He is ...

The Food and Drug Administration ended 2024 with a quartet of notable drug approvals, including three of new medicines that Vertex Pharmaceuticals, Novo Nordisk and Bristol Myers Squibb developed for ...